Next Post

PAI Life Sciences Doses First Healthy Volunteer in Schistosomiasis Vaccine Clinical Trial

Deadly tropical disease threatens hundreds of millions worldwide SEATTLE, May 31, 2022–(BUSINESS WIRE)–PAI Life Sciences, a biotechnology company specializing in translational research for neglected tropical diseases, today announced the dosing of the first healthy volunteer in a clinical trial of SchistoShield®, the company’s preventive vaccine against schistosomiasis, a major tropical […]